177 related articles for article (PubMed ID: 12387195)
1. [Prognostic factors in rheumatoid arthritis].
Rojkovich B; Poór G
Orv Hetil; 2002 Sep; 143(35):2019-26. PubMed ID: 12387195
[TBL] [Abstract][Full Text] [Related]
2. Prognostic markers of radiographic progression in early rheumatoid arthritis.
Goronzy JJ; Matteson EL; Fulbright JW; Warrington KJ; Chang-Miller A; Hunder GG; Mason TG; Nelson AM; Valente RM; Crowson CS; Erlich HA; Reynolds RL; Swee RG; O'Fallon WM; Weyand CM
Arthritis Rheum; 2004 Jan; 50(1):43-54. PubMed ID: 14730598
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis--their relation to disease progression.
Eberhardt K; Grubb R; Johnson U; Pettersson H
J Rheumatol; 1993 Nov; 20(11):1825-9. PubMed ID: 8308765
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
Kaltenhäuser S; Wagner U; Schuster E; Wassmuth R; Arnold S; Seidel W; Tröltzsch M; Loeffler M; Häntzschel H
J Rheumatol; 2001 Apr; 28(4):735-44. PubMed ID: 11327243
[TBL] [Abstract][Full Text] [Related]
5. Predictive markers in rapidly progressing rheumatoid arthritis.
Landewé R
J Rheumatol Suppl; 2007 Nov; 80():8-15. PubMed ID: 17985418
[TBL] [Abstract][Full Text] [Related]
6. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis.
Rojas-Villarraga A; Diaz FJ; Calvo-Páramo E; Salazar JC; Iglesias-Gamarra A; Mantilla RD; Anaya JM
J Autoimmun; 2009 Feb; 32(1):64-9. PubMed ID: 19117726
[TBL] [Abstract][Full Text] [Related]
7. Early aggressive DMARD therapy: the key to slowing disease progression in rheumatoid arthritis.
Hochberg MC
Scand J Rheumatol Suppl; 1999; 112():3-7. PubMed ID: 10668521
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.
Kaltenhäuser S; Pierer M; Arnold S; Kamprad M; Baerwald C; Häntzschel H; Wagner U
Rheumatology (Oxford); 2007 Jan; 46(1):100-4. PubMed ID: 16728439
[TBL] [Abstract][Full Text] [Related]
9. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study.
Combe B; Dougados M; Goupille P; Cantagrel A; Eliaou JF; Sibilia J; Meyer O; Sany J; Daurès JP; Dubois A
Arthritis Rheum; 2001 Aug; 44(8):1736-43. PubMed ID: 11508423
[TBL] [Abstract][Full Text] [Related]
11. Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study.
Plant MJ; Jones PW; Saklatvala J; Ollier WE; Dawes PT
J Rheumatol; 1998 Mar; 25(3):417-26. PubMed ID: 9517757
[TBL] [Abstract][Full Text] [Related]
12. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
[TBL] [Abstract][Full Text] [Related]
13. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis.
Mattey DL; Hassell AB; Dawes PT; Cheung NT; Poulton KV; Thomson W; Hajeer AH; Ollier WE
Arthritis Rheum; 2001 Jul; 44(7):1529-33. PubMed ID: 11465703
[TBL] [Abstract][Full Text] [Related]
14. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
[TBL] [Abstract][Full Text] [Related]
15. Functional impairment and disability in early rheumatoid arthritis--development over 5 years.
Eberhardt KB; Fex E
J Rheumatol; 1995 Jun; 22(6):1037-42. PubMed ID: 7674227
[TBL] [Abstract][Full Text] [Related]
16. Prognostic laboratory markers of joint damage in rheumatoid arthritis.
Lindqvist E; Eberhardt K; Bendtzen K; Heinegård D; Saxne T
Ann Rheum Dis; 2005 Feb; 64(2):196-201. PubMed ID: 15458956
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years.
Flatø B; Lien G; Smerdel A; Vinje O; Dale K; Johnston V; Sørskaar D; Moum T; Ploski R; Førre Ø
J Rheumatol; 2003 Feb; 30(2):386-93. PubMed ID: 12563700
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
Nikolaisen C; Rekvig OP; Nossent HC
Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of the HLA shared epitope for severity of radiological joint damage in patients with rheumatoid arthritis. A 10 year observational prospective study.
Valenzuela-Castaño A; García-López A; Pérez-Vilches D; Rodriguez-Pérez R; Gonzalez-Escribano MF; Núñez-Roldán A
J Rheumatol; 2000 Mar; 27(3):571-4. PubMed ID: 10743791
[TBL] [Abstract][Full Text] [Related]
20. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
Forslind K; Ahlmén M; Eberhardt K; Hafström I; Svensson B;
Ann Rheum Dis; 2004 Sep; 63(9):1090-5. PubMed ID: 15308518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
